Last updated
Menarini Group: Product Launch
Menarini Group reported positive Phase 3 SENTRY trial data for selinexor plus ruxolitinib combination therapy in myelofibrosis, meeting co-primary endpoint with 49.8% spleen volume reduction vs 28% control
- What happened
- Menarini Group reported positive Phase 3 SENTRY trial data for selinexor plus ruxolitinib combination therapy in myelofibrosis, meeting co-primary endpoint with 49.8% spleen volume reduction vs 28% control
- Who
- Menarini Group · Europe
- When
- 2026-06-14
- So what
- The SENTRY readout converts selinexor from a single-agent oncology asset into a validated combination backbone in a fibrosis indication where standard-of-care JAK inhibition alone has ceiling effects.
The leadership read
The SENTRY readout converts selinexor from a single-agent oncology asset into a validated combination backbone in a fibrosis indication where standard-of-care JAK inhibition alone has ceiling effects. That distinction matters operationally: combination-therapy registration requires a more complex regulatory dossier, manufacturing coordination across two drug supply chains, and a market-access argument built on additive clinical benefit rather than class differentiation. Menarini has now committed to all three of those requirements simultaneously. The related signals in this 90-day window are too dispersed across fintech, energy, and EdTech to form a comparable oncology pattern, one should be said plainly. The partial exception is Sichuan Kelun-Biotech's NMPA acceptance of sac-TMT in a new indication, which reflects the same dynamic of regulators processing next-generation oncology combination or expanded-indication filings in parallel with late-stage readouts. That's a thin comparator set, but the directional read holds: hematology-oncology programs reaching Phase 3 data disclosure are compressing the window between trial reporting and regulatory submission. Companies at this stage in European hematology face rising demand for regulatory affairs leadership with EMA combination-product experience, medical affairs capability suited to rare/orphan disease communities, and market-access operators who can construct reimbursement cases around comparative endpoint data rather than simple efficacy claims.
Market context: MitchelLake's Talent Market Index sits at 122.7 (Hot), up 17.8 on the prior month; EMEA hiring signal is running easing (-17.7pts).
Menarini Group: 0 signals in the last 90 days; 3 tracked across 38 days.
MitchelLake in this thematic
Also at Menarini Group →
More signals across EMEA
Product Launch · EMEA
Tauck →Tauck is adding wellness-focused programming (optional fitness, nutrition and mindfulness experiences) to two 2027 departures of its Rendezvous on the Seine river cruise, and plans five Wellness Departures across a broader range of itineraries in 2028.
Product Launch · EMEA
Stargate Hydrogen →Estonia-based Stargate Hydrogen launched a proprietary ceramic catalyst for alkaline electrolyser stacks, claimed to raise output efficiency to 48 kWh/kg and remove dependency on iridium and other platinum-group metals. Available in stacks up to 0.5 MW, with 5 MW stack integration underway; factory capacity stated at 140 MW/yr, expandable to 1 GW+.
Product Launch · EMEA
P2X Solutions →P2X Solutions began injecting renewable e-methane from its Finnish plant into the national gas network, enabling domestic distribution and access to other European markets via the Balticconnector. Gasgrid issued Finland's first guarantees of origin for renewable e-methane from the facility.
Product Launch · EMEA
Baird Architects →US architecture studio Baird Architects released its first furniture collection, the twelve-piece BA Objeto, and says it is already looking ahead to a second collection.
Product Launch · EMEA
Roqqu →Nigerian-founded crypto exchange Roqqu is developing a product to tokenise Nigerian listed equities on blockchain networks and distribute them to eligible investors abroad. It expects Nigerian tokenised securities before 2027, but the regulatory status, launch date and institutional partners are not yet disclosed.
Product Launch · EMEA
Datarails →Datarails, an AI-native financial operating system for the office of the CFO, launched Datarails Spend, an end-to-end spend management offering that ties company spending back to the financial plan.
Where this lands in our work
- Enterprise Innovation & Transformation →
A launch is the output of a product and engineering leadership layer built before it.
- Executive Search: EMEA →
Our EMEA practice runs the searches behind signals like this one.
Intelligence powered by Autonodal ↗